After using this tool, the author reviewed and edited the content as needed and takes full responsibility for this manuscript
These findings suggest that a broader genetic profiling beyond GSTM1 and GSTT1 may further refine the precision application of SFN
The appetite suppression that makes these drugs so effective at driving weight loss also creates a nutritional paradox
Patients receiving the 2.4 mg weekly dose (Wegovy) for weight management may experience more pronounced digestive effects compared to those on lower doses used for diabetes management
These medications are not reviewed or approved by the FDA for safety, efficacy, or quality and may only be obtained with a prescription from a licensed healthcare provider
Pan X, Gong N, Zhao J, Yu Z, Gu F, Chen J, et al